Key points are not available for this paper at this time.
The structure-based drug design (SBDD) leverages the structural insights for rational development of small molecules with optimized affinity/selectivity 1,2. For Mycobacterium tuberculosis (Mt...
Thakur et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: